Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Louzanne Coetzee heading for Paralympic Games in Rio
2016-08-02

Description: Louzanne Coetzee  Tags: Louzanne Coetzee

Louzanne Coetzee (left) from the University of the
Free State and her guide Khothatso Mokone, a former Kovsie,
will compete in the Paralympic Games in Rio de Janeiro,
Brazil, from 7 to 18 September 2016.
Photo: Rufus Botha

Her perseverance and faith. Faith in herself and her coaches, as well as her Christian faith. Rufus Botha says this is what makes the Paralympic athlete Louzanne Coetzee special. According to her coach, the 23-year-old star from the University of the Free State (UFS) is easy to work with. “Her work ethic is incredible. As coach, I actually have to stop her,” he jokes. “She does not like to rest.”

On 19 July 2016, Coetzee was included in South Africa’s Paralympic team for the Olympics in Rio de Janeiro, Brazil. She and her guide Khothatso Mokone, also a former Kovsie, were included in the team that will participate in Rio from 7 to 18 September 2016.

Sights still set on 2020 Olympics

In Brazil, Coetzee will compete in the T11 category in the 1 500 m. The blind athlete is also outstanding in the 800 m and 5 000 m, of which she is the world record holder, but these items do not feature at the Olympics.

Botha says Coetzee has her sights still set on the 2020 Paralympic Games in Tokyo, Japan. “Anything she achieves in Rio will actually be a bonus.” He says it was an achievement on its own to be included in the SA team among established athletes such as Arnu Fourie and Ilse (Hayes) Carstens.

CUADS super proud of record-breaker

“Anything she achieves in Rio
will actually be a bonus.”


“Louzanne is an absolute star and an example to so many Kovsie students,” says Martie Miranda, Head of the Centre for Universal Access and Disability Support (CUADS) at the UFS. “We are super proud of her.”

On 17 July 2016, Coetzee set a new Africa record (5:00:25) in the 1 500 m in Berlin. She will leave for Rio on 30 August 2016, with her heat taking place on 15 September 2016 and the finals on 17 September 2016.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept